Pharmaceutical Technology

SEPTEMBER 2, 2024

The US regulatory agency has also approved updated versions of Covid-19 vaccines from Moderna and Pfizer / BioNTech’s in the past two weeks.

Vaccination 264

Vaccination Vaccine 264

Bio Pharma Dive

SEPTEMBER 4, 2024

Over the past 10 years, PD1-blocking medicines have transformed cancer care. But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes.

Drugs 351

Drugs Medicine 351

pharmaphorum

SEPTEMBER 5, 2024

J&J is reported to have raised its offer to settle claims that its talc products caused cancer by $1.1bn, as it reaches agreement with a holdout law firm.

Production 105

Production 105

Pharmaceutical Commerce

SEPTEMBER 5, 2024

In the second part of her interview with Pharma Commerce Editor Nicholas Saraceno, Ilisa B.G. Bernstein, President of Bernstein Rx Solutions, LLC, discusses the best practices that compliance teams should consider as the end of the stabilization period approaches this November.

Compliance 105

Compliance 105

Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

Fierce Pharma

SEPTEMBER 5, 2024

AstraZeneca has found its employees’ practices under the microscope of Chinese law enforcement years after an insurance fraud case. | AstraZeneca has found its employees’ practices under the microscope of Chinese law enforcement years after an insurance fraud case.

Drugs 127

Drugs 127

Bio Pharma Dive

SEPTEMBER 4, 2024

The funding comes amid a slowdown in venture investment for gene and cell therapy startups, and will support development of multiple solid tumor programs.

Gene 331

Gene Development 331

Pharma Times

SEPTEMBER 5, 2024

Pre-clinical data of VTX-806 in demonstrated normalisation of metabolic parameters

Drugs 152

Drugs 152

Rethinking Clinical Trials

SEPTEMBER 5, 2024

In this Friday’s PCT Grand Rounds, Ardith Doorenbos of the University of Illinois, Chicago, and Diane Flynn of Madigan Army Medical Center will present “Conventional, Complementary, and Integrative Pain Therapies in a Military Population With Chronic Musculoskeletal Pain: Results of a Pragmatic Clinical Trial Using SMART Design.” The Grand Rounds session will be held on Friday, September 6, 2024, at 1:00 pm eastern.

Nurses 144

Nurses Trials Clinical Trials Clinical Trials 144

Bio Pharma Dive

SEPTEMBER 3, 2024

While results from two after-the-fact analyses were “reassuring,” outside experts urged “continued vigilance” to ensure GLP-1 drugs don’t worsen problems in people with preexisting mental health conditions.

Drugs 312

Drugs Research 312

Pharmaceutical Technology

SEPTEMBER 2, 2024

Aptose Biosciences has secured a loan of $10m through a facility agreement with Hanmi Pharmaceutical to develop tuspetinib.

Development 275

Development 275

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Pharma Times

SEPTEMBER 5, 2024

New biomarker test aims to improve early-stage melanoma treatment

146

146

Rethinking Clinical Trials

SEPTEMBER 4, 2024

The National Center for Complementary and Integrative Health (NCCIH), with support from the Helping to End Addiction Long-term ® Initiative, or NIH HEAL Initiative ® , published a notice of funding opportunity for pragmatic clinical trials within the infrastructure of the NIH-DOD-VA Pain Management Collaboratory (PMC). Read the full notice of funding opportunity (RFA-AT-24-011).

Trials 144

Trials Clinical Trials Clinical Trials Research 144

Bio Pharma Dive

SEPTEMBER 5, 2024

New data show Lilly’s longer-lasting insulin matched daily shots in controlling blood sugar, adding to positive findings the company disclosed in May.

Insulin 274

Insulin 274

Pharmaceutical Technology

SEPTEMBER 3, 2024

The UAE has partnered with Novo Nordisk Pharma Gulf to develop a national scientific guide for obesity management and weight control.

Development 268

Development 268

Advertisement

Clinical Supply

Pharma Times

SEPTEMBER 6, 2024

New treatment could simplify diabetes management for millions

Insulin 142

Insulin Trials 142

pharmaphorum

SEPTEMBER 5, 2024

A "small number" of AstraZeneca employees have been detained in China in an investigation into suspected data privacy and drug import breaches

Drugs 133

Drugs 133

Bio Pharma Dive

SEPTEMBER 6, 2024

New trial results could offer support for an expansion of Nucala’s label after U.S. regulators rejected GSK’s submission in 2018.

Trials 265

Trials Antibody Regulation Drugs 265

Pharmaceutical Technology

SEPTEMBER 4, 2024

Actimed says S-oxprenolol shares a similar pharmacology to its lead product S-pindolol, which is being studied in cachexia.

Drugs 263

Drugs Production 263

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Fierce Pharma

SEPTEMBER 4, 2024

Over the last decade, three blockbuster drugs—Biogen’s Spinraza, Roche’s Evrysdi and Novartis’ gene therapy Zolgensma—have transformed the treatment landscape for spinal muscular atrophy (SMA). | Biogen revealed that a portion of its phase 2/3 DEVOTE study met its primary endpoint, as a higher dose of Spinraza improved the motor function of treatment-naive infants with spinal muscular atrophy.

Gene Therapy 114

Gene Therapy Gene Trials Drugs 114

pharmaphorum

SEPTEMBER 5, 2024

Listen to the podcast interview with Manny Belabe from ArisGlobal as he discusses The Life Sciences Generative AI Council and its role in creating a sustainable technological future. Gain insights into the future of AI in life sciences.

Life Science 124

Life Science 124

Bio Pharma Dive

SEPTEMBER 3, 2024

The company's value jumped by several billion dollars as trial results showed its experimental shot could match and, in some cases, even outperform Pfizer's market-leading Prevnar 20.

Vaccine 182

Vaccine Vaccination Trials Marketing 182

Pharmaceutical Technology

SEPTEMBER 2, 2024

GLP-1RAs’ reduce CV risk, including reducing all-cause mortality and risk of MI, promoting weight loss and enhancing blood pressure control.

263

263

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Pharmaceutical Commerce

SEPTEMBER 3, 2024

How can industry stakeholders ensure the quality and supply chain security of existing product?

Drugs 111

Drugs Production 111

pharmaphorum

SEPTEMBER 5, 2024

EU General Court suspends decision to revoke the license for Advanz Pharma's primary biliary cholangitis drug Ocaliva.

Licensing 116

Licensing Licensing Drugs 116

Bio Pharma Dive

SEPTEMBER 3, 2024

Tolebrutinib, which Sanofi acquired in a $3.7 billion deal, failed two studies in people with relapsing disease, but succeeded in a type of multiple sclerosis that has no approved therapies.

Drugs 182

Drugs 182

Pharmaceutical Technology

SEPTEMBER 3, 2024

In clinical supplies, the Importer of Record (IoR) provides a critical service in facilitating logistics and easing the burden for sponsors.

Clinical Supply 260

Clinical Supply Clinical Supply Chain 260

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

Clinical Research

Outsourcing Pharma

SEPTEMBER 3, 2024

Dr Dawn Thompson has over 20 years of experience in building technology platforms that leverage genomics at scale to produce novel products.

Genome 109

Genome Genomics Drugs Production 109

pharmaphorum

SEPTEMBER 3, 2024

EU had no grounds to probe Illumina's takeover of Grail, says ECJ, but while spinoff has already taken place Illumina can now avoid a €432m fine

115

115

Bio Pharma Dive

SEPTEMBER 5, 2024

The departure of Amy Emerson as CEO comes three weeks after the MDMA developer revealed plans to cut 75% of its staff.

Development 173

Development 173

Pharmaceutical Technology

SEPTEMBER 4, 2024

Merck has gained EC approval for KEYTRUDA plus Padcev for adults with unresectable or metastatic urothelial carcinoma.

260

260

Advertisement

Clinical Supply